Mehmet Şenel BADEMCİ, Cemal KOCAASLAN, Ebuzer AYDIN

Nativ arteriyovenöz fistül trombozlarında farmakomekanik ve cerrahi girişimlerin kıyaslanması

Amaç: Bu çalışmada nativ arteriyovenöz fistül trombozunda farmakomekanik trombektomi ile açık cerrahi trombektominin başarı ve açıklık oranları karşılaştırıldı.Ç a l ı ş m a p l a n ı :Ocak 2016 - Aralık 2018 tarihleri arasında nativ arteriyovenöz fistül trombozu olan toplam 96 hasta (56 erkek, 40 kadın; ort. yaş 61±11.7 yıl; dağılım, 26-82 yıl) geriye dönük olarak incelendi. Hastalar farmakomekanik trombektomi (n=42) ve açık cerrahi trombektomi (n=54) olmak üzere iki gruba ayrıldı. Altı ve 12. ayda primer başarısızlık oranı ve primer açıklık oranı kaydedildi.Bul gu lar: Farmakomekaniktrombektomigrubundaki 42 hastadan, 41’ine (%98) ek girişim yapıldı ve dört hastada (%10) primer başarısızlık izlendi. Açık cerrahi grupta 15 hastada (%28) primer başarısızlık görüldü. Altı ve 12. ayda primer açıklık oranları, cerrahi gruba kıyasla, farmakomekanik grupta anlamlı düzeyde daha yüksek idi (sırasıyla, %67’ye kıyasla %85 ve %55’e kıyasla %78; p

Comparison of pharmacomechanical and surgical interventions for thrombosed native arteriovenous fistulas

Background:This study aims to compare success and patency rates of pharmacomechanical thrombectomy versus open surgical thrombectomy for thrombosed native arteriovenous fistulas.Methods: A total of 96 patients (56 males, 40 females; mean age 61±11.7 years; range, 26 to 82 years) with a thrombosed native arteriovenous fistula between January 2016 and December 2018 were retrospectively analyzed. The patients were divided into two groups as pharmacomechanical thrombectomy (n=42) and open surgical thrombectomy (n=54). Primary failure rate and primary patency rate at 6 and 12 months were recorded.Results:Of 42 patients in the pharmacomechanical thrombectomy group, 41 (98%) had additional interventions, and primary failure occurred in four patients (10%). Primary failure was seen in 15 (28%) patients in the surgical group. The primary patency rates at 6 and 12 months were significantly higher in the pharmacomechanical treatment group than the surgical group (85% vs. 67% and 78% vs. 55%, respectively; p

PDF

___

Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M, et al. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006;17(3 Suppl 1):S1-27.
Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006;48 Suppl 1:S176-247.
Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, et al. EBPG on Vascular Access. Nephrol Dial Transplant 2007;22 Suppl 2:ii88-117.
Odabaşı D, Arı E, Kıymaz A, Ekim H. Should we use saphenous vein graft instead of synthetic graft for creation of secondary arteriovenous fistula in hemodialysis dependent end stage renal failure patients? Turk Gogus Kalp Dama 2012:20;209-16.
Bush RL, Lin PH, Lumsden AB. Management of thrombosed dialysis access: thrombectomy versus thrombolysis. Semin Vasc Surg 2004;17:32-9.
Sadaghianloo N, Jean-Baptiste E, Gaid H, Islam MS, Robino C, Declemy S, et al. Early surgical thrombectomy improves salvage of thrombosed vascular accesses. J Vasc Surg 2014;59:1377-84.e1-2.
Kim HK, Kwon TW, Cho YP, Moon KM. Outcomes of salvage procedures for occluded autogenous radiocephalic arteriovenous fistula. Ther Apher Dial 2011;15:448-53.
Rahman A, Özsin KK. Late complications requiring revision of arteriovenous fistulae for hemodialysis. Turk Gogus Kalp Dama 2008;16:167-71.
Bittl JA. Catheter interventions for hemodialysis fistulas and grafts. JACC Cardiovasc Interv 2010;3:1-11.
Lambert G, Freedman J, Jaffe S, Wilmink T. Comparison of surgical and radiological interventions for thrombosed arteriovenous access. J Vasc Access 2018;19:555-60.
Uflacker R, Rajagopalan PR, Selby JB, Hannegan C; Investigators of the Clinical Trial Sponsored by Microvena Corporation. Thrombosed dialysis access grafts: randomized comparison of the Amplatz thrombectomy device and surgical thromboembolectomy. Eur Radiol 2004;14:2009-14.
Lambert G, Freedman J, Jaffe S, Wilmink T. Comparison of surgical and radiological interventions for thrombosed arteriovenous access. J Vasc Access 2018;19:555-60.
Dougherty MJ, Calligaro KD, Schindler N, Raviola CA, Ntoso A. Endovascular versus surgical treatment for thrombosed hemodialysis grafts: A prospective, randomized study. J Vasc Surg 1999;30:1016-23.
Bent CL, Sahni VA, Matson MB. The radiological management of the thrombosed arteriovenous dialysis fistula. Clin Radiol 2011;66:1-12.
Kuhan G, Antoniou GA, Nikam M, Mitra S, Farquharson F, Brittenden J, et al. A meta-analysis of randomized trials comparing surgery versus endovascular therapy for thrombosed arteriovenous fistulas and grafts in hemodialysis. Cardiovasc Intervent Radiol 2013;36:699-705.
Crikis S, Lee D, Brooks M, Power DA, Ierino FL, Levidiotis V. Predictors of early dialysis vascular-access failure after thrombolysis. Am J Nephrol 2008;28:181-9.
Yang CC, Yang CW, Wen SC, Wu CC. Comparisons of clinical outcomes for thrombectomy devices with different mechanisms in hemodialysis arteriovenous fistulas. Catheter Cardiovasc Interv 2012;80:1035-41.
Turmel-Rodrigues L, Pengloan J, Baudin S, Testou D, Abaza M, Dahdah G, et al. Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol Dial Transplant 2000;15:2029-36.
Asif A, Gadalean FN, Merrill D, Cherla G, Cipleu CD, Epstein DL, et al. Inflow stenosis in arteriovenous fistulas and grafts: a multicenter, prospective study. Kidney Int 2005;67:1986-92.
Wilmink T, Hollingworth L, Powers S, Allen C, Dasgupta I. Natural history of common autologous arteriovenous fistulae: Consequences for planning of dialysis. Eur J Vasc Endovasc Surg 2016;51:134-40.
Masengu A, Maxwell AP, Hanko JB. Investigating clinical predictors of arteriovenous fistula functional patency in a European cohort. Clin Kidney J 2016;9:142-7.
Chan PG, Goh GS. Safety and efficacy of the AngioJet device in the treatment of thrombosed arteriovenous fistula and grafts: A systematic review. J Vasc Access 2018;19:243-51.
Vasanthamohan L, Gopee-Ramanan P, Athreya S. The management of cephalic arch stenosis in arteriovenous fistulas for hemodialysis: a systematic review. Cardiovasc Intervent Radiol 2015;38:1179-85.
Rajan DK, Bunston S, Misra S, Pinto R, Lok CE. Dysfunctional autogenous hemodialysis fistulas: outcomes after angioplasty--are there clinical predictors of patency? Radiology 2004;232:508-15.
Dukkipati R, Lee L, Atray N, Kajani R, Nassar G, Kalantar-Zadeh K. Outcomes of cephalic arch stenosis with and without stent placement after percutaneous balloon angioplasty in hemodialysis patients. Semin Dial 2015;28:E7-E10.
Henry JC, Sachdev U, Hager E, Dillavou E, Yuo T, Makaroun M, et al. Cephalic vein transposition is a durable approach to managing cephalic arch stenosis. J Vasc Access 2017 [Online ahead of print]
Tordoir JH, Bode AS, Peppelenbosch N, van der Sande FM, de Haan MW. Surgical or endovascular repair of thrombosed dialysis vascular access: is there any evidence? J Vasc Surg 2009;50:953-6.
Koraen-Smith L, Krasun M, Bottai M, Hedin U, Wahlgren CM, Gillgren P. Haemodialysis access thrombosis: Outcomes after surgical thrombectomy versus catheter-directed thrombolytic infusion. J Vasc Access 2018;19:535-41.
Rajan DK, Clark TW, Simons ME, Kachura JR, Sniderman K. Procedural success and patency after percutaneous treatment of thrombosed autogenous arteriovenous dialysis fistulas. J Vasc Interv Radiol 2002;13:1211-8.
Uflacker R, Rajagopalan PR, Vujic I, Stutley JE. Treatment of thrombosed dialysis access grafts: randomized trial of surgical thrombectomy versus mechanical thrombectomy with the Amplatz device. J Vasc Interv Radiol 1996;7:185-92.
Vesely TM, Williams D, Weiss M, Hicks M, Stainken B, Matalon T, et al. Comparison of the angiojet rheolytic catheter to surgical thrombectomy for the treatment of thrombosed hemodialysis grafts. Peripheral AngioJet Clinical Trial. J Vasc Interv Radiol 1999;10:1195-205.
Zhang Y, Kong X, Tang L, Wei Y, Xu D. Analysis of follow-up methods of vascular access and patient outcomes in hemodialysis at a tertiary care hospital in China. Ther Apher Dial 2018;22:160-5.